Gilead Kedem, M.D., is Director, Bioinformatics, Deerfield Discovery and Development, and joined Deerfield in 2020. Prior to Deerfield, Dr. Kedem spent almost 20 years in biotech, focusing on software development, bioinformatics, genomics, and precision medicine. Most recently, Dr. Kedem consulted for Regeneron Pharmaceuticals and beforehand was Manager, Bioinformatics at GENEWIZ, a global sequencing company. Earlier, Dr. Kedem served as Chief Technology Officer and Chief Medical Officer of a metagenomics-based diagnostics startup. Previously, Mr. Kedem founded a boutique consultancy, Kedem Associates, in Cambridge, Massachusetts, and ran it for over a decade. Kedem Associates developed advanced bioinformatics systems and provided strategic advice for clients engaged in drug discovery, diagnostics, and precision medicine. Dr. Kedem holds a B.S. in Physics from the University of Maryland at College Park, pursued graduate studies in biomedical engineering at Johns Hopkins University, and earned an M.D. from the Sackler School of Medicine at Tel Aviv University, Israel.